TOP BUSINESS

FDA Forces Hims & Hers to Drop Cheap ‘Wegovy’ Knockoff After Regulatory Threats

Hims & Hers cancels its low-cost Wegovy knockoff pill after FDA threats and legal pressure, highlighting regulatory enforcement.

RELATED NEWS

EU Slams TikTok Over ‘Addictive’ Design, Fine Risk

The European Commission has formally charged TikTok with violating the European Union’s online content regulations.

SEC Warns China-Linked Stock Manipulation as Threat to U.S. Investors

SEC Chairman Paul Atkins warns of China-linked “ramp and dump” stock manipulation targeting U.S. investors.

Semiconductor Industry Nears Trillion-Dollar Milestone

The global semiconductor industry is on track to reach a major financial milestone in 2026, with annual revenue projected to exceed $1 trillion.

Hannah Anderson Hails Trump Rx as Game-Changer

Hannah Anderson, Director of Healthy America Policy and Senior Director of Policy at the America First Policy Institute.